跳至主要内容
临床试验/TCTR20221202001
TCTR20221202001
已完成
1 期

Effects of an integrated rehabilitation program on fatigue in patients with pulmonary tuberculosis: A single-centre randomized controlled trial

/A0 个研究点目标入组 68 人2022年12月2日

概览

阶段
1 期
干预措施
未指定
疾病 / 适应症
Fatigue is a symptom frequently encountered in patients with pulmonary tuberculosis.No one has studied fatigue management programs in patients with pulmonary tuberculosis with clarity.
发起方
/A
入组人数
68
状态
已完成
最后更新
去年

概览

简要总结

Before the experiment, The experimental group had a mean score of fatigue (mean 5.47, SD 1.99) and the control group (mean 5.46, SD 1.63). After the 3rd week of trial, the mean scores of the experimental group decreased (mean 4.56, SD 2.01) and the control group (mean 5.54, SD 1.92). At the end of the trial at week 6, the experimental group had mean score of fatigue (mean 3.52, SD 1.98) and the control group had mean score of fatigue.(mean 5.09, SD 2.03)

注册库
who.int
开始日期
2022年12月2日
结束日期
2022年7月26日
最后更新
去年
研究类型
Interventional
性别
All

研究者

发起方
/A

入排标准

入选标准

  • Patients with pulmonary tuberculosis receiving antituberculosis drugs who were 18 years of age or older and had been treated for 2 weeks or more, experience with fatigue, ability to continue daily routines for at least 6 minutes without getting tired, no restrictions on walking and exercising, no cognitive impairment, ability to use the LINE application and communicate by speaking, reading and writing in Thai.

排除标准

  • Patients with comorbidities causing simple fatigue, such as AIDS, cancer with chemotherapy or radiotherapy, emphysema, asthma Stage 4 kidney failure and up, congestive heart failure, a history of COVID\-19 infection, a psychiatric disorder and sleep apnea.

结局指标

主要结局

未指定

相似试验